Article Text

Download PDFPDF
European families reveal MHC class I and II associations with autoimmune-mediated congenital heart block
  1. Nikolaos C Kyriakidis1,
  2. Ingrid Kockum2,
  3. Heikki Julkunen3,
  4. Ariela Hoxha4,
  5. Stina Salomonsson1,
  6. Lauro Meneghel1,
  7. Cathrine Ebbing5,
  8. The Swedish Congenital Heart Block Study Group6,
  9. Alexander Dilthey6,
  10. Marianne Eronen7,
  11. Sara De Carolis8,
  12. Torvid Kiserud5,9,
  13. Amelia Ruffatti4,
  14. Juha Kere10,11,12,
  15. Sabrina Meisgen1,
  16. Marie Wahren-Herlenius1
  1. 1 Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
  2. 2 Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
  3. 3 Department of Internal Medicine and Rheumatology, Helsinki University Central Hospital, Helsinki, Finland
  4. 4 Rheumatology Unit, Department of Medicine, University of Padua, Padua, Italy
  5. 5 Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway
  6. 6 The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK
  7. 7 Health Department, Social Insurance Institution of Finland, Helsinki, Finland
  8. 8 Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy
  9. 9 Department of Clinical Science, University of Bergen, Bergen, Norway
  10. 10 Department of Biosciences and Nutrition, Centre for Innovative Medicine, Karolinska Institutet, Stockholm, Sweden
  11. 11 School of Basic and Medical Biosciences, King’s College London, London, UK
  12. 12 Folkhälsan Institutet of Genetics, and Molecular Neurology Research Program, University of Helsinki, Helsinki, Finland
  1. Correspondence to Professor Marie Wahren-Herlenius, Department of Medicine, Karolinska Institutet, Stockholm 171 76, Sweden ; marie.wahren{at}

Statistics from

Congenital heart block (CHB) may develop in the fetus of Ro/SSA autoantibody-positive women. A population-based recurrence rate of only 12% however suggests that factors other than maternal autoantibodies influence the risk of developing CHB.1 In the present study, we aimed to identify genetic contribution to the disease by analysing HLA associations in European families with a Ro/SSA antibody-positive mother and at least one child affected by CHB.

HLA allele genotypes were imputed for 173 families comprising 635 individuals (291 parents, 173 cases and 167 unaffected siblings) from Sweden, Norway, Finland and Italy (online supplementary table 1) based on 5636 tag SNPs. Parental HLA allele transmission frequencies to patients with CHB were assessed and OR and significance of the association with CHB calculated. We considered nominal P values <0.05 suggestive of significance, and P values below the threshold of Bonferroni correction for multiple testing, or if the association had been previously reported at P<0.05, significant. Detailed information on patients and methods are available online (online supplementary methods).

Supplementary file 1


Supplementary file 2


In the MHC class I gene locus, we replicated the previously identified2 protective association of HLA-Cw*06 (OR 0.22 (0.07–0.67), P=0.003) …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.